Collaborative Medicinal Development Pty Limited   Report issue

For profit Phase 1 Phase 3
Founded: Sydney Australia (2017)

Organization Overview

First Clinical Trial
2017
NCT02688101
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Collaborative Medicinal Development Pty Limited

Active Ingredients

Drugs in Phase 3 Trials (1)

cu(ii)atsm (5 trials)

Drugs in Phase 1 Trials (1)

dpc (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Amyotrophic Lateral Sclerosis (Phase 3)

Motor Neuron Disease (Phase 3)

Parkinson Disease (Phase 1)

Sclerosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 2